Opportunity Information: Apply for RFA DK 27 122

The funding opportunity titled "Single Source for the Continuation of the Physiology of the Weight Reduced State (POWERS) Study (U01 - Clinical Trials Required)" is an NIH Notice of Funding Opportunity (NOFO) that supports the continuation of an ongoing clinical trial known as POWERS. POWERS is focused on a central problem in obesity and weight management research: many people are able to lose weight through lifestyle interventions, but a large proportion regain some or all of that weight over time, and the degree of regain varies widely from person to person. The study is designed to dig into the physiology behind that variability, looking for the biological and metabolic processes that influence who maintains weight loss and who is more likely to regain.

The immediate purpose of this NOFO is not to launch a new project from scratch, but to ensure the existing POWERS clinical trial can be completed as planned and that the substantial data and biospecimens already collected can be fully analyzed. In practical terms, the award is meant to keep the trial infrastructure operating through completion, support required clinical-trial coordinating activities, and enable the downstream scientific work that turns participant measurements and specimen collections into interpretable findings. The emphasis on analyzing both collected data and biospecimens signals that the continuation work is expected to include rigorous statistical analysis and laboratory or biomarker-related analysis based on stored samples, rather than focusing only on additional recruitment or new experimental arms.

This is a single-source competition, meaning NIH is explicitly seeking one application from a specific entity rather than inviting broad competition across many institutions. The NOFO invites an application from the Data Coordinating Center (DCC) for the POWERS consortium, and NIDDK specifically indicates the continuation will be at the University of Pittsburgh. Even though the general eligibility list includes a wide range of applicant types (such as state and local governments, tribal entities, nonprofits, higher education institutions, and for-profit organizations), the single-source language and the reference to Section III eligibility effectively limit who is expected to apply. The structure reflects a common NIH approach when a complex, multi-year clinical trial is already underway and continuity is critical; switching coordinating centers midstream can create avoidable risk, inefficiency, and disruptions to established protocols, data systems, and oversight processes.

The award mechanism is a U01 cooperative agreement with clinical trials required. A cooperative agreement differs from a standard research grant in that NIH staff typically have substantial scientific and/or programmatic involvement during the project period. For a clinical trial, this often translates into active collaboration on milestones, performance monitoring, data quality and harmonization expectations, and oversight of safety, compliance, and reporting requirements. Because the NOFO is tied to an ongoing clinical trial, the continuation award is essentially positioned to maintain the operational backbone needed to meet trial obligations and deliver final scientific outputs.

Administratively, the opportunity is issued by the National Institutes of Health (NIH), with the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) as the institute requesting the single-source competition. The Funding Opportunity Number is RFA-DK-27-122, and the Assistance Listing/CFDA number provided is 93.847, which corresponds to diabetes, endocrine, and metabolic disease research support. The activity category is listed as Health, consistent with the clinical focus on obesity-related physiology and metabolic outcomes.

The NOFO anticipates making one award (Expected Awards: 1), reinforcing that this is intended to fund a single coordinating entity to carry the trial to completion. The posting lists an original closing date of 2026-11-17, and a creation date of 2026-10-15. While an award ceiling is not specified in the provided text, the cooperative agreement format and the one-award expectation imply a targeted continuation budget aligned with the needs of trial completion, coordination, and analysis, rather than a broad exploratory funding pool.

Finally, even though the competition is single-source, the application is still expected to go through standard NIH peer review. The NOFO makes clear that peer review will occur under NIH processes and that only meritorious applications will be considered for funding. In other words, NIH is signaling both the importance of continuity for this particular trial and the expectation that the continuation plan must still demonstrate scientific value, operational readiness, appropriate stewardship of the trial and its datasets, and a credible path to completing analyses and producing impactful results.

  • The National Institutes of Health in the health sector is offering a public funding opportunity titled "Single Source for the Continuation of the Physiology of the Weight Reduced State (POWERS) Study (U01- Clinical Trials Required)" and is now available to receive applicants.
  • Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.847.
  • This funding opportunity was created on 2026-10-15.
  • Applicants must submit their applications by 2026-11-17. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
  • The number of recipients for this funding is limited to 1 candidate(s).
  • Eligible applicants include: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal governments (Federally recognized), Public housing authorities/Indian housing authorities, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education, Private institutions of higher education, For-profit organizations other than small businesses, Small businesses, Others.
Apply for RFA DK 27 122

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:

Frequently Asked Questions (FAQ)

What is the title of this funding opportunity?

The opportunity is titled "Single Source for the Continuation of the Physiology of the Weight Reduced State (POWERS) Study (U01 - Clinical Trials Required)."

Which agency is offering this grant opportunity?

The opportunity is issued by the National Institutes of Health (NIH).

Which NIH institute is requesting this award?

The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) is the institute requesting this single-source competition.

What is the Funding Opportunity Number?

The Funding Opportunity Number is RFA-DK-27-122.

What is the Assistance Listing (CFDA) number?

The Assistance Listing/CFDA number provided is 93.847.

What general research area does CFDA 93.847 correspond to?

CFDA 93.847 corresponds to diabetes, endocrine, and metabolic disease research support, which aligns with the obesity and metabolic focus of the POWERS study.

What is the activity category for this opportunity?

The activity category is Health.

What is POWERS?

POWERS is an ongoing clinical trial focused on a central problem in obesity and weight management research: many people lose weight through lifestyle interventions, but a large proportion regain some or all of that weight over time, and the amount of regain varies widely across individuals.

What scientific question is POWERS trying to answer?

The study is designed to investigate the physiology behind why weight regain differs from person to person, including biological and metabolic processes that may influence who maintains weight loss and who is more likely to regain.

Is this NOFO intended to start a brand-new project?

No. The immediate purpose is to support the continuation of the existing POWERS clinical trial so it can be completed as planned, and so that data and biospecimens already collected can be fully analyzed.

What is the main purpose of the continuation award?

The award is intended to keep the trial infrastructure operating through completion, support required clinical-trial coordinating activities, and enable downstream scientific work needed to turn the collected measurements and biospecimens into interpretable findings.

What types of work are emphasized for the continuation?

The description emphasizes rigorous analysis of both previously collected data and stored biospecimens. This signals a focus on statistical analyses and laboratory/biomarker-related analyses based on existing samples, rather than primarily focusing on launching new experimental arms.

What grant mechanism is being used?

The award mechanism is a U01 cooperative agreement.

Are clinical trials required under this U01?

Yes. The opportunity is explicitly labeled "Clinical Trials Required" and is tied to the continuation of an ongoing clinical trial.

What does it mean that this is a cooperative agreement (U01) rather than a standard research grant?

A cooperative agreement typically means NIH staff will have substantial scientific and/or programmatic involvement during the project period. For a clinical trial continuation, this often includes active collaboration around milestones, performance monitoring, expectations for data quality and harmonization, and oversight related to safety, compliance, and reporting.

What does "single-source competition" mean in this NOFO?

It means NIH is explicitly seeking one application from a specific entity rather than inviting broad competition among many institutions.

Who is the NOFO inviting to apply?

The NOFO invites an application from the Data Coordinating Center (DCC) for the POWERS consortium.

Which organization is identified for the continuation?

NIDDK specifically indicates the continuation will be at the University of Pittsburgh.

If the eligibility section lists many applicant types, can any organization apply?

Even though the general eligibility list includes a wide range of applicant types, the single-source language and the reference to Section III eligibility effectively limit who is expected to apply for this continuation award.

Why would NIH use a single-source approach for an ongoing clinical trial?

The description reflects a common NIH approach for complex, multi-year clinical trials where continuity is critical. Switching coordinating centers midstream can add risk and inefficiency and can disrupt established protocols, data systems, and oversight processes.

How many awards does NIH expect to make?

The NOFO anticipates making one award (Expected Awards: 1).

Does the NOFO include an award ceiling?

An award ceiling is not specified in the provided text.

What does the one-award expectation imply about the budget?

It implies the funding is targeted to continuation needs such as trial completion, coordination, and analysis, rather than being a broad exploratory funding pool.

What are the key dates listed for this opportunity?

The creation date is 2026-10-15, and the original closing date is 2026-11-17.

Will applications still undergo NIH peer review even though it is single-source?

Yes. The NOFO states that peer review will occur under NIH processes and that only meritorious applications will be considered for funding.

What is NIH signaling by requiring peer review for a single-source continuation?

NIH is signaling that while continuity for this specific trial is important, the continuation plan must still demonstrate scientific value, operational readiness, responsible stewardship of the trial and its datasets, and a credible plan for completing analyses and producing impactful results.

What kinds of responsibilities are implied for the coordinating entity under this continuation?

Based on the description, responsibilities include maintaining the operational backbone needed to meet clinical trial obligations, continuing coordinating activities, ensuring data quality and harmonization expectations are met, supporting oversight requirements, and enabling final analyses of both datasets and biospecimens.

Browse more opportunities from the same agency: National Institutes of Health

Browse more opportunities from the same category: Health

Next opportunity: Fiscal Year 2026 Wildlife Crossings Pilot Program

Previous opportunity: U.S. Embassy Bishkek Public Diplomacy American Corners

Applicant Portal:

Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.

Apply for RFA DK 27 122

 

Applicants also applied for:

Applicants who have applied for this opportunity (RFA DK 27 122) also looked into and applied for these:

Funding Opportunity
Palliative Care Research Across the Lifespan: Leveraging the Palliative Care Consortium (R01 Clinical Trial Optional) Apply for PAR 27 090

Funding Number: PAR 27 090
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Centers for AIDS Research (CFAR) and Developmental Centers for AIDS Research (D-CFAR) (P30 Clinical Trial Not Allowed) Apply for PAR 28 090

Funding Number: PAR 28 090
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Implementation Science to Advance HIV Prevention, Treatment, and Care (R61/R33 Clinical Trial Optional) Apply for RFA AI 27 018

Funding Number: RFA AI 27 018
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Carcinogen Hazard Assessment Monographs Program (CHAMP) (R01 Clinical Trial Not Allowed) Apply for RFA CA 28 013

Funding Number: RFA CA 28 013
Agency: National Institutes of Health
Category: Health
Funding Amount: $700,000
Centers for Structural Biology of HIV and Other Infectious Diseases (U54 Clinical Trial Not Allowed) Apply for RFA AI 28 031

Funding Number: RFA AI 28 031
Agency: National Institutes of Health
Category: Health
Funding Amount: $3,500,000
Limited Competition: Biospecimen Banks to support NCI National Clinical Trials Network Biospecimen Banks (NCTN Biobanks) and the NCI Early-Phase and Experimental Clinical Trials Biospecimen Bank (EET Biobank) (U24 Clinical Trial Not Allowed) Apply for RFA CA 28 004

Funding Number: RFA CA 28 004
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Specialized Alcohol Research Centers (P50 Clinical trial Optional) Apply for RFA AA 28 001

Funding Number: RFA AA 28 001
Agency: National Institutes of Health
Category: Health
Funding Amount: $1,150,000
NIH Research Program Projects (Parent P01 Clinical Trial Optional) Apply for PA 27 061

Funding Number: PA 27 061
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
HEAL Initiative: Whole Joint Health Program (R61/R33 Clinical Trial Required) Apply for PAR 27 045

Funding Number: PAR 27 045
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
NLM Institutional Grants for Research Training in Biomedical Informatics, Data Science, and AI (T15 Independent Clinical Trial Not Allowed) Apply for RFA LM 28 001

Funding Number: RFA LM 28 001
Agency: National Institutes of Health
Category: Health
Funding Amount: $775,000
Collaborative Program Grant for Interdisciplinary Teams (RM1 Clinical Trial Optional) Apply for PAR 27 003

Funding Number: PAR 27 003
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Pilot Projects to Enhance the Human Virome Program (R03 Clinical Trials Not Allowed) Apply for RFA RM 27 024

Funding Number: RFA RM 27 024
Agency: National Institutes of Health
Category: Health
Funding Amount: $100,000
Early-Onset Cancers: Investigating Etiology, Mechanisms, and Early Detection Strategies (RP1 Clinical Trials Optional) Apply for PAR 28 014

Funding Number: PAR 28 014
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Cellular Senescence Network (SenNet): SenNet Data Coordination and Integration Center (SenNet DCIC) (UM1 Clinical Trials Not Allowed) Apply for RFA RM 27 025

Funding Number: RFA RM 27 025
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Accelerating Research and Development of Next Generation Vaccines against Malaria - a Model for Mosquito-Borne Diseases (R61/R33 Clinical Trial Not Allowed) Apply for RFA AI 28 024

Funding Number: RFA AI 28 024
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent

 

Grant application guides and resources

It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!

Apply for Grants

 

Inside Our Applicants Portal

  • Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
  • Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
  • Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Access Applicants Portal

 

Premium leads for funding administrators, grant writers, and loan issuers

Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.

If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.

Learn More

 

 

Request more information:

Would you like to learn more about this funding opportunity, similar opportunities to "RFA DK 27 122", eligibility, application service, and/or application tips? Submit an inquiry below:

Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.

 

Ask a Question: